Collegium Pharmaceutical Inc
COLLHealthcare|Drug Manufacturers - Specialty & Generic|USA
$35.22
-0.59 (-1.65%)
DCF (FCF)
$54.10
Earnings Power
$22.35
Upcoming Data Readouts (3)
Sep 2026
Est. completion
NANeuropathic Pain
Analysis of Selected Biochemical Parameters in Cerebrospinal Fluid and Peripheral Blood in the Treatment of Neuropathic Pain Using Spinal Cord Stimulation (SCS)
NCT07153211n=30
Nov 2026
Est. completion
IBD and Renal Involement
Renal Dysfunction in Patients With Inflammatory Bowel Disease and the General Population (NEPHRO-IBD)
NCT07593352n=6,000
Apr 2028
Est. completion
NAACL Injury
The Efficiency and Safety of PRP Treatment After Anterior Cruciate Ligament Reconstruction.
NCT06442319n=60